Nurix Therapeutics (NRIX) Research & Development (2019 - 2025)
Historic Research & Development for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $83.0 million.
- Nurix Therapeutics' Research & Development rose 2350.35% to $83.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $316.9 million, marking a year-over-year increase of 4298.61%. This contributed to the annual value of $316.9 million for FY2025, which is 4298.61% up from last year.
- According to the latest figures from Q4 2025, Nurix Therapeutics' Research & Development is $83.0 million, which was up 2350.35% from $86.1 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Research & Development ranged from a high of $86.1 million in Q3 2025 and a low of $23.0 million during Q1 2021
- In the last 5 years, Nurix Therapeutics' Research & Development had a median value of $47.8 million in 2022 and averaged $51.4 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 8752.77% in 2022, then plummeted by 364.26% in 2023.
- Quarter analysis of 5 years shows Nurix Therapeutics' Research & Development stood at $36.5 million in 2021, then increased by 26.21% to $46.1 million in 2022, then rose by 7.82% to $49.7 million in 2023, then soared by 35.22% to $67.2 million in 2024, then increased by 23.5% to $83.0 million in 2025.
- Its Research & Development stands at $83.0 million for Q4 2025, versus $86.1 million for Q3 2025 and $78.1 million for Q2 2025.